Related references
Note: Only part of the references are listed.Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis
Zhefeng Lou et al.
CANCER CELL INTERNATIONAL (2021)
A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer
Xuan Deng et al.
CELL DEATH & DISEASE (2021)
Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway
Quanlin Liu et al.
DIAGNOSTIC PATHOLOGY (2021)
The Critical Role of TRIB2 in Cancer and Therapy Resistance
Victor Mayoral-Varo et al.
CANCERS (2021)
Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
Jia Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer
Xiao Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Trib1 regulates T cell differentiation during chronic infection by restraining the effector program
Kelly S. Rome et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century
Dianne Pulte et al.
BLOOD CANCER JOURNAL (2020)
ABLGenomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
Shu-Huey Chen et al.
CANCERS (2020)
Recurrence-Associated Long Non-coding RNA LNAPPCC Facilitates Colon Cancer Progression via Forming a Positive Feedback Loop with PCDH7
Ting Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
ONECUT2 Accelerates Tumor Proliferation Through Activating ROCK1 Expression in Gastric Cancer
Jie Chen et al.
CANCER MANAGEMENT AND RESEARCH (2020)
circ-ZUFSP regulates trophoblasts migration and invasion through sponging miR-203 to regulate STOX1 expression
Zhifang Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Chloroquine Combined with Imatinib Overcomes Imatinib Resistance in Gastrointestinal Stromal Tumors by Inhibiting Autophagy via the MAPK/ERK Pathway
Song Zheng et al.
ONCOTARGETS AND THERAPY (2020)
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma
Jianxing Yin et al.
EBIOMEDICINE (2019)
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells
Zhenhong Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation
Simona Bernardi et al.
CANCER MEDICINE (2019)
Fra-1 and c-Fos N-Terminal Deletion Mutants Impair Breast Tumor Cell Proliferation by Blocking Lipid Synthesis Activation
Ana Cristina Racca et al.
FRONTIERS IN ONCOLOGY (2019)
被撤回的出版物: Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression (Retracted article. See MAY, 2023)
Shukun Han et al.
CELL CYCLE (2019)
Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity
Halil Ciftci et al.
MOLECULES (2019)
LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1
Janfei Tu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition
Myung Jin Ban et al.
CANCER SCIENCE (2018)
TRIB2 regulates the differentiation of MLL-TET1 transduced myeloid progenitor cells
Hyeng-Soo Kim et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling
Zhenlin Hou et al.
MOLECULAR CANCER (2018)
miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma
Marta Diaz-Martinez et al.
CANCER RESEARCH (2018)
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway
Dong Ren et al.
MOLECULAR CANCER (2017)
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Richard Hill et al.
NATURE COMMUNICATIONS (2017)
TRIB2 contributes to cisplatin resistance in small cell lung cancer
Yuanxin Liang et al.
ONCOTARGET (2017)
Tribbles breaking bad: TRIB2 suppresses FOXO and acts as an oncogenic protein in melanoma
Wolfgang Link
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Impact of Long-Term Exposure to the Tyrosine Kinase Inhibitor Imatinib on the Skeleton of Growing Rats
Josephine T. Tauer et al.
PLOS ONE (2015)
Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K/Akt Pathway and the Expression of P-gp and MRP1
Hongye Ma et al.
PLOS ONE (2014)
被撤回的出版物: S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells (Retracted article. See vol. 15, 2020)
Minghua Yang et al.
PLOS ONE (2014)
Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia
Jorge Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells
Nicholas B. Heaney et al.
BLOOD (2010)
ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokines
Valentina Nardi et al.
BLOOD (2009)
High rates of durable response are achieved with imatinib after treatment with interferon α plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial
Francois Guilhot et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Share Paper
